| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.58B | +34.7% |
| R&D Expense | $829.0M | +92.8% |
| SG&A Expense | $1.15B | +43.9% |
| Operating Income | -$1.12B | -148.7% |
| Interest Expense | $2.0M | -85.7% |
| Pre-tax Income | -$1.40B | -202.2% |
| Income Tax | -$31.0M | -720.0% |
| Net Income | -$1.36B | -191.7% |
| EPS (Basic) | -$3.68 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.98B | -21.0% |
| Accounts Receivable | $400.0M | +14.6% |
| Current Assets | $4.72B | +3.4% |
| Total Assets | $9.79B | +43.8% |
| Current Liabilities | $2.54B | +44.5% |
| Total Liabilities | $3.02B | +41.0% |
| Stockholders' Equity | $6.75B | +44.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $367.0M | -47.0% |
| Capital Expenditures | $176.0M | +36.4% |
| Investing Cash Flow | -$300.0M | +85.3% |
| Financing Cash Flow | -$375.0M | +22.4% |
| Free Cash Flow | $191.0M | -66.1% |
| -164.7% |
| EPS (Diluted) | -$3.68 | -164.7% |